(15009138), K. S. R., (22687839), J. S. L., (15352499), M. M. M., (14850778), C. U. B., (22687842), I. R., (22687845), F. T., . . . (15027870), I. V. (2025). Figure S1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Citazione stile Chigago Style (17a edizione)(15009138), Kristoffer Staal Rohrberg, et al. Figure S1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. 2025.
Citatione MLA (9a ed.)(15009138), Kristoffer Staal Rohrberg, et al. Figure S1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. 2025.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.